Company Filing History:
4 out of 666 
1 out of 147 
Years Active: 2013-2016
Title: The Innovative Contributions of Beverly Folmer
Introduction
Beverly Folmer is a distinguished inventor based in Hockessin, Delaware. She has made significant contributions to the field of medicinal chemistry, particularly in the development of Janus kinase inhibitors. With a total of 4 patents to her name, her work has the potential to impact the treatment of various diseases.
Latest Patents
Among her latest patents are innovative compounds that serve as Janus kinase inhibitors. One notable patent involves N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines. These compounds are particularly useful in treating JAK-associated diseases, including inflammatory and autoimmune disorders, as well as cancer. Another patent focuses on substituted tricyclic heteroaryl compounds, such as pyridoindoles, pyrimidinoindoles, and triazinoindoles, which modulate the activity of Janus kinases and are beneficial in treating immune-related diseases, skin disorders, and myeloid proliferative disorders.
Career Highlights
Beverly has worked with prominent companies in the pharmaceutical industry, including Incyte Corporation and Incyte Holdings Corporation. Her expertise in medicinal chemistry has allowed her to contribute to groundbreaking research and development in the field.
Collaborations
Throughout her career, Beverly has collaborated with notable professionals, including James David Rodgers and Argyrios George Arvanitis. These collaborations have further enhanced her research and innovation in the field of Janus kinase inhibitors.
Conclusion
Beverly Folmer's contributions to medicinal chemistry and her innovative patents highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in the treatment of various diseases.